Stallion India Fluorochemicals Signs MoU with Rajasthan Govt for ₹200 Cr HFO Plant
Stallion India Fluorochemicals Limited signed an MoU with the Government of Rajasthan to set up an HFO manufacturing plant in Bhilwara. The company proposes an investment of ₹200 crore for the facility, with work beginning in 2027. Management is confident in achieving a 30-35% revenue CAGR over the next three years.
The investment of ₹200 crore in a new HFO manufacturing plant represents a substantial expansion and strategic move towards advanced refrigerant solutions, which is expected to have a significant impact on the company's future growth and market position.
The announcement details a significant investment in a new manufacturing plant and expresses confidence in future revenue growth, indicating a positive outlook for the company.
Stallion India Fluorochemicals Limited (SIFL) has signed a Memorandum of Understanding (MoU) with the Government of Rajasthan to establish a Hydrofluoroolefin (HFO) manufacturing plant in Bhilwara (Hurda), Rajasthan. This initiative is part of the company's planned capacity expansion program, with an investment of approximately ₹200 crore earmarked for the HFO facility. The commencement of work on the production plant is slated for 2027.
Mr. Shazad Rustomji, Managing Director & CEO of SIFL, commented that the MoU signifies an important milestone in the company's expansion towards sustainable refrigerant solutions. He highlighted that HFOs represent the next generation of low-global-warming-potential refrigerants, and the proposed facility will enhance their product portfolio and long-term competitiveness. The company is executing its expansion in a phased manner, with the R32 project targeted for commissioning by October 2026, followed by the initiation of the HFO manufacturing plant. SIFL is confident in achieving its targeted 30–35% revenue CAGR over the next three years, aligning with India's self-reliance vision in specialty and fluorochemicals, thereby creating sustainable long-term value for stakeholders.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under strategic partnerships. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.